Indivior CFO reports equity vesting and tax withholding

Indivior Pharmaceuticals, Inc. Chief Financial Officer Ryan Preblick reported equity award activity involving performance stock units and common stock.

Rhea-AI Filing Summary

Indivior Pharmaceuticals, Inc. Chief Financial Officer Ryan Preblick reported equity award activity involving performance stock units and common stock. In 2024, 204,904 shares vested from performance stock units granted on March 3, 2021 and were subject to a further two-year holding period. On March 3, 2026, this holding period ended and 87,597 shares were withheld to satisfy tax withholding obligations. On the same date, 86,949 shares of common stock vested from performance stock units granted on March 3, 2023 after performance conditions were determined to be met at 76.6% of a 113,510 share target. Each performance stock unit represents a contingent right to receive one share of common stock. After these transactions, Preblick held 317,292 shares of Indivior common stock directly.

Insider Trade Summary

113,510 shares exercised/converted

Exercise 3 txns

Insider Preblick Ryan

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Performance Stock Units	113,510	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	87,597	$31.98	$2.80M
Exercise	Common Stock	86,949	$0.00	$0.00

Holdings After Transaction: Performance Stock Units — 0 contracts (Direct); Common Stock — 317,292 shares (Direct)

Footnotes (3)

1. F1. In 2024, 204,904 shares vested in respect of performance stock units granted to the Reporting Person on March 3, 2021. These shares were subject to a further two-year holding period. On March 3, 2026, the holding period ended and 87,597 shares were withheld to satisfy tax withholding obligations.
2. F2. Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period.
3. F3. Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.

FAQ

What insider transactions did Indivior (INDV) CFO Ryan Preblick report?

Indivior CFO Ryan Preblick reported performance stock unit vesting and related common stock activity. Awards granted in 2021 and 2023 vested, with some shares converted to common stock and 87,597 shares withheld on March 3, 2026 to cover tax obligations tied to these equity awards.

How many performance stock units vested for Indivior (INDV) CFO from 2021 awards?

For awards granted on March 3, 2021, 204,904 shares vested in 2024 for the Indivior CFO. These shares were then subject to a two-year holding period, which ended on March 3, 2026, when a portion was withheld to satisfy tax withholding obligations.

What performance outcome was applied to Indivior (INDV) CFO’s 2023 performance stock units?

The 2023 performance stock units for the Indivior CFO vested based on performance conditions being met at 76.6%. Out of a 113,510 share target amount, 86,949 shares vested on March 3, 2026, and these vested shares will be released following a two-year holding period.

How many Indivior (INDV) shares were withheld for the CFO’s tax obligations?

On March 3, 2026, 87,597 shares of Indivior common stock were withheld to satisfy tax withholding obligations. These shares relate to equity awards that had vested and completed a required holding period before the tax-withholding disposition occurred.

What is the relationship between Indivior (INDV) performance stock units and common stock?

Each Indivior performance stock unit represents a contingent right to receive one share of the company’s common stock. When performance conditions and any applicable holding periods are met, vested performance stock units convert into an equivalent number of common shares for the reporting person.

How many Indivior (INDV) common shares did the CFO hold after these transactions?

After the reported March 3, 2026 transactions, Chief Financial Officer Ryan Preblick directly held 317,292 shares of Indivior common stock. This figure reflects the net result of vested awards, conversions, and shares withheld for tax obligations associated with his equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Preblick Ryan

(Last) (First) (Middle)

10710 MIDLOTHIAN TURNPIKE

SUITE 125

(Street)

NORTH CHESTERFIELD VA 23235

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Indivior Pharmaceuticals, Inc. [ INDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		F		87,597(1)	D	$31.98	230,343	D
Common Stock	03/03/2026		M		86,949(2)	A	(3)	317,292	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Units	$0(3)	03/03/2026		M			113,510	03/03/2028(2)	(2)	Common Stock	113,510	(3)	0	D

Explanation of Responses:

1. In 2024, 204,904 shares vested in respect of performance stock units granted to the Reporting Person on March 3, 2021. These shares were subject to a further two-year holding period. On March 3, 2026, the holding period ended and 87,597 shares were withheld to satisfy tax withholding obligations.

2. Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period.

3. Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.

Remarks:

	/s/Alice Givens, Power of Attorney	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.